Results 171 to 180 of about 3,006,184 (303)

Screening for precapillary pulmonary hypertension in chronic myeloproliferative disorders: the role of N-terminal pro-B-type natriuretic peptide and vascular endothelial growth factor - a pilot study. [PDF]

Arch Med Sci, 2021
Költő G, Tőkés-Füzesi M, Papp E, Adravetz Z, Komócsi A, Egyed M, Faludi R.   +6 more
europepmc   +1 more source

Refractory Gingival Enlargement: A Critical Oral Clue to Early‐Stage Granulomatosis With Polyangiitis—A Case Report and Literature Review

Case Reports in Dentistry, Volume 2026, Issue 1, 2026.
Introduction Granulomatosis with polyangiitis (GPA), formerly known as Wegener′s granulomatosis, is a rare, systemic small‐vessel vasculitis characterized by necrotizing granulomatous inflammation. It classically affects the upper airway, lungs, and kidneys.
Sarwer Biplob, Rahmi Amtha, Najla Nadiah, Rachendra Pratama, Tommaso Lombardi   +4 more
wiley   +1 more source

COVID-19 in Philadelphia-negative myeloproliferative disorders: a GIMEMA survey. [PDF]

Leukemia, 2020
Breccia M, Piciocchi A, De Stefano V, Finazzi G, Iurlo A, Fazi P, Soddu S, Martino B, Palandri F, Siragusa S, Albano F, Passamonti F, Vignetti M, Vannucchi AM.   +13 more
europepmc   +1 more source

JAK Inhibitors as a Novel Approach to Autoimmune Bullous Diseases: A Review

Dermatologic Therapy, Volume 2026, Issue 1, 2026.
Autoimmune bullous diseases (AIBDs) are a group of chronic disorders characterized by blister formation resulting from abnormal immune responses. Janus kinase (JAK) inhibitors have emerged as promising therapeutic agents for AIBDs. This review discusses the use of JAK inhibitors—such as upadacitinib, baricitinib, tofacitinib, and abrocitinib, among ...
Olga Olisova, Yuliya Kolesova, Natalia Teplyuk, Ekaterina Grekova, Leyi Ni, Alina Mardanova, Karim Karray, Anastasiia Tikhonova, Anfisa Lepekhova, Jaime Piquero-Casals   +9 more
wiley   +1 more source

Megakaryocytic features useful for the diagnosis of myeloproliferative disorders can be obtained by a novel unsupervised software analysis. [PDF]

, 2006
Claudio Tripodo, Cesare Valenti, Benedetto Ballarò, Zbigniew Rudzki, Domenico Tegolo, Vito Di Gesù, Ada Maria Florena, Vito Franco   +7 more
openalex   +1 more source

Treatment of gastric varices with partial splenic embolization in a patient with portal vein thrombosis and a myeloproliferative disorder

, 2014
Robert Gianotti
openalex   +2 more sources

Identification of the JAK2 V617F Mutation in Chronic Myeloproliferative Disorders Using FRET Probes and Melting Curve Analysis [PDF]

, 2006
Gurunathan Murugesan, Samer Aboudola, Hadrian Szpurka, Mary Ann Verbic, Jaroslaw P. Maciejewski, Raymond R. Tubbs, Eric D. Hsi   +6 more
openalex   +1 more source

Genetic and epigenetic alterations of myeloproliferative disorders

International journal of hematology, 2013
J. Milosevic, R. Kralovics
semanticscholar   +1 more source

Subarachnoid hemorrhage and diplopia as initial presentation of polycythemia vera [PDF]

, 2005
Christian Opherk, Gerhard F. Hamann, Hannah L. Pellkofer, Landolfi R, Martin Dichgans, Michiels JJ, Pearson TC, Polycythemia, Roland Brüning   +8 more
core   +1 more source

Rapid detection of JAK2 V617F mutation in myeloproliferative disorders [PDF]

, 2016
Rashid Mir, F. M. Abu‐Duhier
openalex   +1 more source